Chengfeng Zhang

12 Wulumuqi Middle Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

AI and the Third Dimension: Towards Objective Outcome Assessment in Vitiligo.

AI and the Third Dimension: Towards Objective Outcome Assessment in Vitiligo.

Journal: The British journal of dermatology

Published: August 02, 2026

Oral JAK inhibitors combined with 308-nm excimer laser in pediatric progressive vitiligo: Further considerations and future directions.

Oral JAK inhibitors combined with 308-nm excimer laser in pediatric progressive vitiligo: Further considerations and future directions.

Journal: Journal of the American Academy of Dermatology

Published: March 24, 2026

A set-theoretic configurational analysis of sports event policy change: insights from Shanghai.

A set-theoretic configurational analysis of sports event policy change: insights from Shanghai.

Journal: Frontiers in physiology

Published: November 18, 2025

Efficacy and Safety of 590 Nm and 590/630 Nm Light-Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial.

Efficacy and Safety of 590 Nm and 590/630 Nm Light-Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial.

Journal: Photodermatology, photoimmunology & photomedicine

Published: November 16, 2025

Clinical and molecular markers of vitiligo: a narrative review of early-stage insights into disease activity and treatment response.

Clinical and molecular markers of vitiligo: a narrative review of early-stage insights into disease activity and treatment response.

Journal: The British journal of dermatology

Published: November 11, 2025

Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Journal: The Journal of dermatological treatment

Published: October 17, 2025

When Conventional Therapy Fails: Interleukin-36 Inhibition for Severe Hydroxychloroquine-Induced Acute Generalized Exanthematous Pustulosis in Systemic Lupus Erythematosus - A Case Report.

When Conventional Therapy Fails: Interleukin-36 Inhibition for Severe Hydroxychloroquine-Induced Acute Generalized Exanthematous Pustulosis in Systemic Lupus Erythematosus - A Case Report.

Journal: Case reports in dermatology

Published: October 16, 2025

Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications.

Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications.

Journal: The Journal of investigative dermatology

Published: October 14, 2025

Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2/RhoA/YAP pathway.

Effect of platelet-rich plasma in refractory vitiligo by promoting the differentiation of dermal melanocyte progenitors via IGFBP-2/RhoA/YAP pathway.

Journal: Journal of advanced research

Published: October 04, 2025

Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study.

Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study.

Journal: The Journal of investigative dermatology

Published: August 30, 2025

Isotretinoin combined with oral tranexamic acid for moderate-to-severe acne vulgaris: Evidence gaps and future directions.

Isotretinoin combined with oral tranexamic acid for moderate-to-severe acne vulgaris: Evidence gaps and future directions.

Journal: Journal of the American Academy of Dermatology

Published: August 13, 2025

Diffuse Annular Plaques in a Man in his 70s.

Diffuse Annular Plaques in a Man in his 70s.

Journal: International journal of dermatology

Published: July 24, 2025

Showing 1-12 of 79

Last Updated: 09/26/2026